TRAIL与kallistatin联合表达载体的构建及抗肿瘤活性分析

为研究肿瘤坏死因子相关凋亡诱导配体(TRAIL)与组织激肽释放酶结合蛋白(kallistatin)联合用药的抗肿瘤作用,构建TRAIL与kallistatin双表达的重组质粒pAM-CAG-Kal-IRES-TRAIL,将重组质粒转染A549,LO-2,NCI-H446和Hela细胞,考察其抗肿瘤活性.实验结果表明:构建的双表达载体能同时表达TRAIL与kallistatin,且均能分泌至培养基中;TRAIL与kallistatin联合表达对肿瘤细胞活力的抑制作用明显增强,诱导肿瘤凋亡的作用也明显增强,说明联合表达TRAIL与kallistatin能够增强抗肿瘤活性.     

凋亡抑制蛋白与肿瘤关系的研究

凋亡抑制蛋白(inhibitor of apoptosis proteins,IAPs)可以作为癌症诊断和治疗的靶点,在肿瘤研究方面备受关注,就凋亡抑制蛋白的结构、功能、在肿瘤中的表达与肿瘤的关系等研究进展作一综述,为凋亡抑制蛋白的研究提供信息和思路.     

Surface molecules regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-MB-468 breast carcinoma cells and their interaction

The extravasation of leukocytes and tumor cells is a multi-step process with the involvement of various adhesion molecules depending on the three steps rolling, adhesion, and diapedesis. We have developed an in vitro model, by which we investigated the rolling and adhesion of neutrophil granulocytes and MDA-MB-468 human breast carcinoma cells to lung endothelial cells under physiological flow-conditions. We found that norepinephrine had an inhibitory function on the fMLP-promoted adhesion of neutrophil granulocytes due to a down-regulation of β2-integrin. Furthermore, neutrophil granulocytes serve as linking cells for the interaction of the MDA-MB-468 cells with the endothelium, which are both β2-integrin negative, but express the β2-integrin ligand ICAM-1. In addition, we show here that N-cadherin is up-regulated on the endothelial cells and on neutrophil granulocytes in response to fMLP. This up-regulation resulted in a significant increase of adherent MDA-MB-468 cells, which are also N-cadherin positive. Received 3 September 2007; received after revision 17 October 2007; accepted 22 October 2007     

家兔膀胱动脉的解剖学研究

用血管铸型和透明方法观察了家兔膀胱的血供情况。膀胱动脉主要起自脐动脉，沿膀胱侧缘行向膀胱顶，沿途发出１～４支基本对称的分支分布于膀胱前面，两侧膀胱动脉的分支在其表面有吻合现象。膀胱动脉及其分支均呈不同程度的弯曲或弹簧状，可能是适应膀胱生理性增大的结构基础。     

肿瘤患者的心理分析及护理

分析了肿瘤患者心理变化4个阶段的不同表现,并针对此提出相应心理护理的方式。指出加强肿瘤患者的心理分析及护理是保证顺利治愈的重要环节。     

鸭血烯酸对艾氏癌生长的抑制作用

鸭血烯酸是由鸭血清中提取的不饱和脂肪酸．在体外实验中具有使艾氏腹水癌细胞膨胀失活的作用．用于治疗艾氏癌患鼠,可抑制其腹水癌和实体瘤的生长．与环磷酰胺（CPA）或氟脲嘧啶（SFU）相比,鸭血烯酸的毒性较低,疗效较高,约20％～40％被治愈的患鼠,可长期存活．     

长吻鮠肾和膀胱的组织结构

长吻鮠的肾脏由肾小体、肾小管、集合管及拟淋巴组织等构成．肾小体在肾前段最多(2．2个／mm^2)，中段次之(约1．7个／mm^2)，后段最少(约1个／mm^2)；拟淋巴组织在肾的中后段逐渐增多；肾小球直径较小，在60～78μm之间；膀胱体积远比一般真骨鱼类大，移行上皮中有大型分泌细胞，最大径达100μm．纵肌和环肌同等发达，厚280～700μm。     

颈部肿块细针吸取细胞学诊断

2000—2002年进行颈部肿块细针吸取细胞学检查共600例，有病理组织学证实138例，其中恶性病变66例。淋巴结、甲状腺各占60．10％、23．50％。细胞学阳性158例，占26．33％，可疑恶性32例，占5．33％。和术后病理组织学诊断对照。恶性病变符合率80．30％，良性病变符合率为93．06％，总符合率为86．96％。敏感率(阳性 可疑)淋巴结、甲状腺分别为96．29％和90．00％。本文对假阳性、假阴性病例进行了分析。     

复方癌立消抗肿瘤活性的研究

癌立消为验方，取长白山新鲜中药配制而成，实验用NIH小鼠移植Ehrlieh癌造成实体瘤模型。随机分四组。对照组不给药，阳性对照组给环磷酰胺剂量100mg／kg、癌立消剂量为成人剂量5倍(2．6g／kg)和10倍(5．2g／kg)两组。结果表明：癌立消有明显的抑瘤作用。5倍成人剂量组抑瘤率为43．9％-50．4％，10倍成人剂量组为53．3％-56．3％，而且有统计学意义。     

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system

The human adenovirus type 5 E1A, a tumor- suppressor gene[1], codes for two major related proteins of 243 amino acids (12S) and 289 amino acids (13S) by al-ternative splicing in two exons[2]. Studies have been shown that E1A can regulate expression of many genes and cell cycle[3]. Both in vitro and in vivo experiments indicated that E1A could induce tumor cells differentia-tion, convert tumor cells into an epithelial phenotype, in-hibit tumor cell growth and metastasis and strongly en-ha…